1. Home
  2. PVH vs CNTA Comparison

PVH vs CNTA Comparison

Compare PVH & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PVH Corp.

PVH

PVH Corp.

HOLD

Current Price

$67.40

Market Cap

3.2B

ML Signal

HOLD

Logo Centessa Pharmaceuticals plc

CNTA

Centessa Pharmaceuticals plc

HOLD

Current Price

$28.02

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PVH
CNTA
Founded
1881
2020
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
3.5B
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
PVH
CNTA
Price
$67.40
$28.02
Analyst Decision
Buy
Strong Buy
Analyst Count
16
9
Target Price
$89.27
$40.89
AVG Volume (30 Days)
787.4K
1.2M
Earning Date
03-31-2026
05-13-2026
Dividend Yield
0.22%
N/A
EPS Growth
N/A
N/A
EPS
3.72
N/A
Revenue
$8,652,900,000.00
N/A
Revenue This Year
$3.66
N/A
Revenue Next Year
$1.79
N/A
P/E Ratio
$18.06
N/A
Revenue Growth
N/A
N/A
52 Week Low
$59.28
$9.60
52 Week High
$89.79
$30.58

Technical Indicators

Market Signals
Indicator
PVH
CNTA
Relative Strength Index (RSI) 56.59 57.19
Support Level $60.58 $24.62
Resistance Level $72.09 $30.29
Average True Range (ATR) 2.18 1.53
MACD 0.45 -0.05
Stochastic Oscillator 96.85 71.20

Price Performance

Historical Comparison
PVH
CNTA

About PVH PVH Corp.

PVH designs and markets branded apparel in more than 40 countries. Its key fashion categories include men's dress shirts, ties, sportswear, underwear, and jeans. Its two designer brands, Calvin Klein and Tommy Hilfiger, now generate practically all its revenue after its recent disposition of most of its smaller brands. PVH operates e-commerce sites, about 1,400 stores, and about 1,500 shop-in-shops and concessions. The firm also licenses its brands to third parties and distributes its merchandise through department stores and other wholesale accounts. PVH traces its history to 1881 and is based in New York City.

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.

Share on Social Networks: